nafamostat has been researched along with Uremia in 8 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogata, H | 1 |
| Kinugasa, E | 2 |
| Hara, S | 1 |
| Ubara, Y | 1 |
| Matsuo, T | 3 |
| Wanaka, K | 1 |
| Kario, K | 1 |
| Yamada, T | 1 |
| Matsuo, M | 2 |
| Fujisawa, K | 1 |
| Matsumoto, Y | 1 |
| Muramatsu, H | 1 |
| Shinzato, T | 1 |
| Hiramatsu, K | 1 |
| Horie, K | 1 |
| Cai, Z | 1 |
| Oka, H | 1 |
| Amano, I | 1 |
| Muramatsu, T | 1 |
| Maeda, K | 1 |
| Ouga-Maruyama, S | 1 |
| Nishitani, H | 1 |
| Kim, CW | 1 |
| Yamakawa, M | 1 |
| Nishizawa, Y | 1 |
| Morii, H | 1 |
| Makita, T | 1 |
| Akizawa, T | 1 |
| Koshikawa, S | 1 |
2 reviews available for nafamostat and Uremia
| Article | Year |
|---|---|
[Treatment of uremic patients with high bleeding risk].
Topics: Anticoagulants; Benzamidines; Blood Platelet Disorders; Guanidines; Hemorrhage; Heparin, Low-Molecul | 2004 |
[Uremic pericarditis].
Topics: Anticoagulants; Benzamidines; Cardiac Surgical Procedures; Death; Dialysis; Drainage; Glucocorticoid | 2007 |
1 trial available for nafamostat and Uremia
| Article | Year |
|---|---|
Increased serum midkine levels during hemodialysis using heparin in chronic renal failure.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anticoagulants; Benzamidines; Carrier Proteins; Cytokines; | 1998 |
5 other studies available for nafamostat and Uremia
| Article | Year |
|---|---|
Management of uremic patients with heparin-induced thrombocytopenia requiring hemodialysis.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arginine; Benzamidines; Female; Guanidines; Heparin; Humans | 2008 |
Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Benzamidines; Blood Coagulation Factors; Blood | 1994 |
Can nafamostat mesilate be used for temporary management of hemodialysis in a patient with heparin-induced thrombocytopenia (HIT)?
Topics: Anticoagulants; Benzamidines; Guanidines; Heparin; Humans; Male; Middle Aged; Platelet Activation; P | 2001 |
[Upper gastrointestinal complications in uremic patients with dialysis].
Topics: Benzamidines; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Guanidines; H | 1992 |
[Treatment of uremic patients at high bleeding risk].
Topics: Benzamidines; Blood Transfusion; Deamino Arginine Vasopressin; Gabexate; Guanidines; Hemorrhage; Hep | 1992 |